Boenning & Scattergood’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.76M | Sell |
9,624
-916
| -9% | -$262K | 0.44% | 55 |
|
|
2022
Q3 | $3.41M | Buy |
10,540
+916
| +10% | +$296K | 0.7% | 36 |
|
|
2022
Q2 | $3.12M | Hold |
9,624
| – | – | 0.59% | 42 |
|
|
2022
Q1 | $2.76M | Buy |
9,624
+27
| +0.3% | +$7.73K | 0.44% | 55 |
|
|
2021
Q4 | $2.65M | Buy |
9,597
+225
| +2% | +$62.2K | 0.42% | 58 |
|
|
2021
Q3 | $2.17M | Sell |
9,372
-75
| -0.8% | -$17.3K | 0.38% | 67 |
|
|
2021
Q2 | $2.17M | Buy |
9,447
+125
| +1% | +$28.7K | 0.38% | 71 |
|
|
2021
Q1 | $1.74M | Buy |
9,322
+600
| +7% | +$112K | 0.33% | 81 |
|
|
2020
Q4 | $1.47M | Buy |
8,722
+7
| +0.1% | +$1.18K | 0.31% | 90 |
|
|
2020
Q3 | $1.29M | Buy |
8,715
+254
| +3% | +$37.6K | 0.31% | 81 |
|
|
2020
Q2 | $1.39M | Buy |
8,461
+3,105
| +58% | +$510K | 0.37% | 67 |
|
|
2020
Q1 | $743K | Sell |
5,356
-15
| -0.3% | -$2.08K | 0.26% | 101 |
|
|
2019
Q4 | $706K | Hold |
5,371
| – | – | 0.18% | 136 |
|
|
2019
Q3 | $601K | Sell |
5,371
-75
| -1% | -$8.39K | 0.17% | 146 |
|
|
2019
Q2 | $603K | Buy |
5,446
+425
| +8% | +$47.1K | 0.18% | 145 |
|
|
2019
Q1 | $652K | Sell |
5,021
-2,400
| -32% | -$312K | 0.2% | 133 |
|
|
2018
Q4 | $859K | Sell |
7,421
-2,840
| -28% | -$329K | 0.3% | 97 |
|
|
2018
Q3 | $1.1M | Buy |
10,261
+400
| +4% | +$42.9K | 0.35% | 78 |
|
|
2018
Q2 | $841K | Buy |
+9,861
| New | +$841K | 0.28% | 107 |
|